760139

0

INVICTA

img img img img
No Data Available

Invicta Diagnostic Ltd Share Price Update

INVICTA DIAGNOSTIC LTD made its market debut on 2025-12-08 and is currently trading at ₹76.2, down by ₹-1.80 from its previous close. Today's session has seen the stock move between ₹76.00 and ₹79.85.

Invicta Diagnostic Ltd performance

Today’s low Today’s high
₹ 76.00 ₹ 79.85
₹ 76.20
52 week low 52 week high
₹ 58.10 ₹ 105.00
₹ 76.20
Open Price ₹ 78.00
Prev. Close ₹ 78.00
Volume (Shares) 19200.00
Total traded value ₹ 14.63
Upper Circuit ₹ 93.60
Lower Circuit ₹ 62.40
info

Investment Returns

Over 1 Month 6.94% Over 3 Months 20.00% Over 6 Months -21.19% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Invicta Diagnostic Ltd fundamentals


  • Market cap (Cr) 95.80
  • P/E Ratio (TTM) 17.80
  • Beta 1.28
  • Book Value / share 38.92
  • Return on equity 44.39%
  • EPS (TTM) 4.28
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

Invicta Diagnostic Ltd Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Book Value / Share 19.99
ROE % 32.33
ROCE % 43.55
Total Debt to Total Equity 0.12
EBITDA Margin 31.83
Particulars MAR 2024 (Values in Cr)
Book Value / Share 925.99
ROE % 22.09
ROCE % 19.72
Total Debt to Total Equity 0.15
EBITDA Margin 46.93
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.60
ROE % 44.39
ROCE % 56.85
Total Debt to Total Equity 0.00
EBITDA Margin 48.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 717.10
ROE % 25.45
ROCE % 25.77
Total Debt to Total Equity 0.00
EBITDA Margin 80.29
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.16
Total Assets 21.25
Total Liabilities 21.25
Total Equity 15.83
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 22.07
Return on Capital (%) 26.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.33
Total Assets 15.83
Total Liabilities 15.83
Total Equity 11.14
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 16.97
Return on Capital (%) 20.67
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.80
Total Assets 17.49
Total Liabilities 17.49
Total Equity 14.81
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 30.76
Return on Capital (%) 36.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.88
Total Assets 11.05
Total Liabilities 11.05
Total Equity 9.42
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 21.71
Return on Capital (%) 25.45
Particulars MAR 2025 (Values in Cr)
Net Income 6.86
Cash from Operations 7.57
Cash from Investing -5.22
Cash from Financing -0.42
Net change in Cash 0.82
Free Cash Flow 8.12
Particulars MAR 2024 (Values in Cr)
Net Income 2.68
Cash from Operations 5.32
Cash from Investing -10.00
Cash from Financing 7.13
Net change in Cash 1.33
Free Cash Flow 18.08
Particulars MAR 2025 (Values in Cr)
Net Income 6.86
Cash from Operations 5.61
Cash from Investing -4.21
Cash from Financing 0.00
Net change in Cash -0.08
Free Cash Flow 5.82
Particulars MAR 2024 (Values in Cr)
Net Income 2.42
Cash from Operations 5.08
Cash from Investing -9.51
Cash from Financing 5.34
Net change in Cash 0.88
Free Cash Flow 10.05
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7725.65 61.15 12.22 111082.99 6680.00 8099.00
FORTIS MALAR HOSPITALS LIMITED 58.01 23.97 3.16 108.72 40.75 82.90
SHREE PACETRONIX LTD. 141.90 21.40 3.13 53.21 66.10 283.15
TRANSGENE BIOTEK LTD. 2.85 0.00 2.34 21.59 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7725.65 76.48 11.92 111082.99 6680.00 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.80 0.00 -11.27 28.98 30.02 57.48
KOVAI MEDICAL CENTER & HO 5640.40 26.17 5.18 6170.60 5010.00 6725.00

Invicta Diagnostic Ltd shareholding pattern

Holding
22.14%
66.69%
0.94%
10.21%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Invicta Diagnostic Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
76.20 -2.30 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 77.60
  • 26 Days 73.30
  • 10 Days 76.60
  • 50 Days 72.40
  • 12 Days 76.10
  • 100 Days 72.50
  • 20 Days 74.30
  • 200 Days 72.50
79.00 PIVOT
First Support 77.00 First Resistance 80.00 Second Support 76.00 Second Resistance 82.00 Third Support 74.00 Third Resistance 83.00
RSI 54.69 ADX 28.81 MACD 2.75 Williams % R -38.26 Commodity Channel Index (CCI) 76.12
Date 2026-04-24 Week 13600.00 Same Day 12800.00 Month 21840.00
1 Year 1.28 3 Year 1.29
Over 1 Month
6.94% down
Over 1 Year
0.00% down
Over 3 Months
20.00% down
Over 3 Years
0.00% down
Over 6 Months
-21.19% down
Over 5 Years
0.00% down

Invicta Diagnostic Ltd Corporate Actions

Top Gainers

Top Losers

Invicta Diagnostic Ltd Share Price

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre. Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023. Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre.

Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and
pathology solutions. It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

The business and brand 'PC Diagnostics' were conceptualised and founded by Dr. Ketan Jayantilal Jain and Dr. Sanket Vinod Jain, Promoters and Non-Executive directors, who are a first-generation entrepreneur in healthcare and have more than 10 years and 7 years of experience, respectively, in integrated diagnostics business and both are a radiologist. The Promoter and Chief Financial Officer, Rohit Prakash Srivastava, have been involved in our business and operations since 2021 as Management Advisor.

The history dates back to 2021, when the Promoters established the first 'PC Diagnostics' Centre in Thane, Maharashtra having the entire gamut of services including PET CT Scans, CT Scans, MRI Scans, Sonography, X-Ray and Pathology. The test menu includes pathology tests ranging from basic biochemistry and clinical pathology which are performed at their own centres to cytogenetics and high-end molecular diagnostic tests which are outsourced to larger reference laboratories, and radiology tests from basic echocardiograms, X-rays and ultrasounds to advanced radiology tests including computerised tomography (CT) scans, magnetic resonance imaging (MRI) scans and advanced positron emission tomography CT (PET CT).

The Company acquired majority shareholding in 'PCD Diagnostics LLP' for a full-fledged diagnostic centre in Marol, Andheri East, forming it as the subsidiary in 2023. Thereafter, it acquired majority shareholding in 'Primacare Healthcare LLP' for a full-fledged diagnostic centre in Byculla, forming it as subsidiary and further acquired majority shareholding in 'Pratham MRI and CT Scan Centre' for a full-fledged diagnostic centre in Bhayandar, forming it a subsidiary in 2023.

In 2024, the Company acquired a diagnostic centre in Sewri from PCD Medical LLP, acquired a diagnostic centre in Parel from Primacare Diagnostic LLP and acquired a centralised laboratory in Parel from Porteus Path Lab LLP. The Company further formed 'Invicta Medical LLP' as a subsidiary for setting up of diagnostic centre in Kalwa, Thane in 2024.

In FY 2025, Company acquired Porteus Medical LLP, 'Primacare Diagnostic LLP, for setting up of a diagnostic centre in Dadar, Mumbai, making it a subsidiary of the Company.

The Company came up with its initial public offering by issuing 33,08,000 equity shares of Rs 10 each by raising Rs 28.12 crores in December 2025.

Parent organization Indian Private
NSE symbol INVICTA
Founded 2023
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Invicta Diagnostic Ltd?

Answer Field

Invicta Diagnostic Ltd share price is for NSE ₹ 76.20 & for BSE ₹ 0.00 as on Apr 24 2026 03:15 PM.

What is the Market Cap of Invicta Diagnostic Ltd Share?

Answer Field

The market cap of Invicta Diagnostic Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Apr 24 2026 03:15 PM.

What is the 52 Week High and Low of Invicta Diagnostic Ltd?

Answer Field

The 52 Week High and Low of Invicta Diagnostic Ltd for NSE is ₹ 105.00 and ₹ 58.10 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Invicta Diagnostic Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Invicta Diagnostic Ltd Share?

Answer Field

As on Apr 24 2026 03:15 PM the price-to-earnings (PE) ratio for Invicta Diagnostic Ltd share is 17.80.

What is the PB ratio of Invicta Diagnostic Ltd Share?

Answer Field

As on Apr 24 2026 03:15 PM, the price-to-book (PB) ratio for Invicta Diagnostic Ltd share is 38.92.

How to Buy Invicta Diagnostic Ltd Share?

Answer Field

You can trade in Invicta Diagnostic Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Invicta Diagnostic Ltd Share on Bajaj Broking App?

Answer Field

To buy Invicta Diagnostic Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Invicta Diagnostic Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|